查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1982822

2026-2034年全球催產素市場規模、佔有率、趨勢和成長分析報告

Global Oxytocin Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計催產素市場將從 2025 年的 9,022 萬美元成長到 2034 年的 1.9146 億美元，2026 年至 2034 年的複合年成長率預計為 8.72%。

由於對有效孕產婦護理的需求不斷成長，全球催產素市場正穩步成長。催產素是一種廣泛用於產科的激素，用於引產、控制產後出血和處理分娩併發症。隨著世界各地的醫療保健系統越來越重視改善孕產婦健康，對催產素製劑的需求也不斷成長，尤其是在醫院和婦產科醫療中心。

多種因素共同推動了這一市場的成長。許多開發中國家出生率的上升以及孕產婦保健意識的增強是主要驅動力。此外，各國政府和世界衛生組織正在推廣使用催產素來預防產後出血，產後出血是導致孕產婦死亡的主要原因之一。同時，藥品生產和分銷網路的改善也使得農村地區和醫療服務匱乏的地區更容易獲得催產素。

鑑於孕產婦和新生兒健康仍然是全球醫療保健舉措的重點，催產素市場前景仍然光明。新興經濟體醫療保健基礎設施的擴建將提高產科藥物的可近性。此外，旨在改善藥物穩定性和儲存條件的持續研究有望提高催產素的療效和可近性，尤其是在醫療資源有限的地區。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球催產素市場：依適應症分類

  • 市場分析、洞察與預測
  • 交付前
  • 產後

第5章：全球催產素市場：依分銷管道分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 藥局
  • 網路藥房

第6章：全球催產素市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Novartis AG
    • Pfizer Inc
    • Fresenius Kabi LLC
    • Ferring BV
    • Hikma Pharmaceuticals PLC
    • Endo International Plc（Par Sterile Products LLC）
    • Teva Pharmaceutical Industries Ltd
    • Mylan NV
    • Sun Pharmaceutical Industries Ltd
    • Yuhan Corporation
    • Wockhardt Ltd
簡介目錄
Product Code: VMR11212628

The Oxytocin Market size is expected to reach USD 191.46 Million in 2034 from USD 90.22 Million (2025) growing at a CAGR of 8.72% during 2026-2034.

The global oxytocin market is growing steadily due to the increasing demand for effective maternal healthcare treatments. Oxytocin is a hormone widely used in obstetrics to induce labor, control postpartum bleeding, and manage complications during childbirth. As healthcare systems worldwide place greater emphasis on improving maternal health outcomes, the demand for oxytocin-based medications is increasing, particularly in hospitals and maternity care centers.

Several factors are contributing to the growth of this market. Rising birth rates in many developing countries and increasing awareness about maternal healthcare are key drivers. Governments and international health organizations are also promoting the use of oxytocin to prevent postpartum hemorrhage, which is one of the leading causes of maternal mortality. Additionally, improvements in pharmaceutical manufacturing and distribution networks are making oxytocin more accessible in rural and underserved areas.

The future of the oxytocin market is expected to remain positive as global healthcare initiatives continue to prioritize maternal and neonatal health. Expanding healthcare infrastructure in emerging economies will likely increase the availability of obstetric medicines. Furthermore, ongoing research aimed at improving drug stability and storage conditions may enhance the effectiveness and accessibility of oxytocin, particularly in regions with limited medical resources.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indication

  • Antepartum
  • Postpartum

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

COMPANIES PROFILED

  • Novartis AG, Pfizer Inc, Fresenius Kabi LLC, Ferring BV, Hikma Pharmaceuticals PLC, Endo International plc Par Sterile Products LLC, Teva Pharmaceutical Industries Ltd, Mylan NV, Sun Pharmaceutical Industries Ltd, Yuhan Corporation, Wockhardt Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL OXYTOCIN MARKET: BY INDICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Indication
  • 4.2. Antepartum Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Postpartum Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OXYTOCIN MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Distribution Channel
  • 5.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OXYTOCIN MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Indication
    • 6.2.2 By Distribution Channel
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Indication
    • 6.3.2 By Distribution Channel
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Indication
    • 6.4.2 By Distribution Channel
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Indication
    • 6.5.2 By Distribution Channel
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Indication
    • 6.6.2 By Distribution Channel
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL OXYTOCIN INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Novartis AG
    • 8.2.2 Pfizer Inc
    • 8.2.3 Fresenius Kabi LLC
    • 8.2.4 Ferring B.V
    • 8.2.5 Hikma Pharmaceuticals PLC
    • 8.2.6 Endo International Plc (Par Sterile Products LLC)
    • 8.2.7 Teva Pharmaceutical Industries Ltd
    • 8.2.8 Mylan N.V
    • 8.2.9 Sun Pharmaceutical Industries Ltd
    • 8.2.10 Yuhan Corporation
    • 8.2.11 Wockhardt Ltd